Accelerated biological and phenotypic aging in hematopoietic cell transplant survivors: Social support as a protective factor
造血细胞移植幸存者的生物和表型衰老加速:社会支持作为保护因素
基本信息
- 批准号:10421443
- 负责人:
- 金额:$ 11.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAdoptedAdultAftercareAgeAgingAttentionBehavioralBehavioral ResearchBiologicalBiological AgingBiological TestingBiteBlood specimenBuffersCancer SurvivorshipCell AgingCellular StressCharacteristicsClinicalCognitiveConflict (Psychology)DNA DamageDNA MethylationDataDimensionsDisease ProgressionElementsEmotionalEpigenetic ProcessFacultyFamilyFamily memberFatigueFriendsFundingGene ExpressionGene Expression ProfilingGenomicsGoalsHealthHealth PsychologyHematologic NeoplasmsIndividualInflammationInterventionK-Series Research Career ProgramsKnowledgeLate EffectsLengthLinkMediatorMemoryMentorshipMuscle WeaknessOccupationalOxidative StressPainParticipantPathway interactionsPhenotypePopulationProcessProviderPsychosocial StressPublic HealthQuality of lifeRecoveryRegimenReportingResearchResourcesRestScientistSex DifferencesSocial FunctioningSocial IdentificationSocial InteractionSocial ProcessesSocial supportSourceSpouse CaregiverSpousesStressSurvival RateSurvivorsSymptomsTestingTimeTrainingTransplant RecipientsTransplantation ConditioningWomanWorkage relatedagedbehavior observationbehavior predictionbiobehaviorcell growthcollaborative environmentdesigndisabilityexperiencefrailtyfunctional declinefunctional genomicsgenome-widehealthspanhematopoietic cell transplantationimprovedin vivoinnovationmenmiddle ageprematureprimary caregiverprospectiveprotective factorspsychologicreduce symptomssocialsocial influencesocial relationshipssoundstem cell proliferationtelomeretooltranscriptome sequencingtransplant survivor
项目摘要
PROJECT SUMMARY/ABSTRACT
Hematopoietic cell transplantation (HCT) is a widely used treatment for hematologic cancers; however, many
survivors experience late effects that resemble an accelerated aging phenotype, or age-related functional
declines thought to be manifestations of aging at the cellular level. Indeed, emerging evidence suggests that
HCT can accelerate biological aging in survivors by up to 15 years. Not all survivors experience these late
effects, suggesting that modifiable behavioral factors may influence vulnerability. Given the intense
psychological and biological demands of HCT, the recovery period may represent a “window of opportunity” in
which behavioral factors such as social support may exert a particular influence. Emerging evidence suggests
that social experiences can impact key biological aging pathways in non-cancer populations; however, whether
they contribute to variability in accelerated aging in HCT survivors has not been tested. The overarching goal
of the proposed research is to examine the influence of social relationships on biological and phenotypic aging
in HCT recipients over the first year of recovery. Specifically, this project will: (1) examine associations
between social processes and symptoms of phenotypic aging; (2) examine associations between social
processes and biological aging; (3) test biological aging as a mediator linking social processes and phenotypic
aging; and (4) explore sex differences in associations between social process and biological and phenotypic
aging. Adopting a prospective design, this research will comprehensively assess survivors’ social relationships
at critical 100-day and 1-year post-HCT time points by combining reports of social support, strain, and isolation
with an innovative, in vivo behavioral observation tool, the Electronically Activated Recorder, that captures
ambient sound bites to unobtrusively assess social interactions in survivors’ daily lives. Participants will provide
reports of symptoms to characterize phenotypic aging, including cognitive, physical (e.g., fatigue, pain, frailty),
and functional complaints, and blood samples to assess biological aging pathways, including cellular
senescence, inflammation, DNA damage, and oxidative stress assessed via genome-wide transcriptional
profiling. This research has the potential to identify concrete, modifiable behavioral targets that contribute to
biological and phenotypic aging processes in HCT recipients and can be used to develop biologically informed
interventions to improve quality of life and prolong the healthspan of individuals with accelerated aging. This
career development award will expand the candidate’s existing expertise in clinical health psychology and
behavioral research by providing training in biological and phenotypic aging and functional genomics in the
context of cancer survivorship. The proposed research, along with mentorship from a team of expert faculty
(Dr. Carroll, Dr. Bower, Dr. Seeman, and Dr. Cole), and the interdisciplinary environment and resources
available at UCLA, will prepare the candidate to become a fully independent research scientist in the field of
aging and biobehavioral health.
项目总结/摘要
造血细胞移植(HCT)是一种广泛用于血液癌症的治疗;然而,许多造血干细胞移植(HCT)是一种非常有效的治疗方法。
幸存者经历类似于加速老化表型或年龄相关功能的晚期效应,
细胞水平的衰老表现。事实上,新出现的证据表明,
HCT可以加速幸存者的生物衰老长达15年。并不是所有的幸存者都经历过
影响,这表明可改变的行为因素可能会影响脆弱性。考虑到
HCT的心理和生物学需求,恢复期可能代表一个“机会之窗”,
哪些行为因素如社会支持可能会产生特定的影响。新出现的证据表明
社会经历可以影响非癌症人群的关键生物衰老途径;然而,
它们对HCT存活者加速老化的可变性的贡献尚未得到测试。总体目标
这项研究的目的是检验社会关系对生物和表型衰老的影响
在HCT接受者恢复的第一年。具体而言,本项目将:(1)研究协会
社会过程和表型衰老症状之间的联系;(2)检查社会过程和表型衰老症状之间的联系。
过程和生物老化;(3)测试生物老化作为连接社会过程和表型的中介
年龄;(4)探索社会过程与生物和表型之间的关联的性别差异
衰老本研究采用前瞻性设计,对幸存者的社会关系进行全面评估
在HCT后关键的100天和1年时间点,通过结合社会支持、紧张和隔离的报告
一个创新的,在体内的行为观察工具,电子激活记录器,
环境声音片段,以不引人注目地评估幸存者日常生活中的社会互动。参与者将提供
表征表型衰老的症状报告,包括认知,身体(例如,疲劳、疼痛、虚弱),
和功能性投诉,以及血液样本,以评估生物老化途径,包括细胞
通过全基因组转录评估衰老、炎症、DNA损伤和氧化应激
侧写这项研究有可能确定具体的,可改变的行为目标,有助于
HCT接受者的生物学和表型衰老过程,并可用于开发生物信息
采取干预措施,提高加速老化者的生活质量,延长其健康寿命。这
职业发展奖将扩大候选人在临床健康心理学方面的现有专业知识,
通过提供生物学和表型衰老以及功能基因组学方面的培训,
癌症生存的背景。这项拟议中的研究,沿着来自专家团队的指导
(Dr.卡罗尔、鲍尔博士、西曼博士和科尔博士),以及跨学科的环境和资源
可在加州大学洛杉矶分校,将准备候选人成为一个完全独立的研究科学家在该领域的
衰老和生物行为健康。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Associations of religious and existential variables with psychosocial factors and biomarkers of cardiovascular risk in bereavement.
- DOI:10.1111/acel.14014
- 发表时间:2024-01
- 期刊:
- 影响因子:7.8
- 作者:
- 通讯作者:
Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients.
- DOI:10.3389/fimmu.2022.877558
- 发表时间:2022
- 期刊:
- 影响因子:7.3
- 作者:
- 通讯作者:
Chronic stress increases transcriptomic indicators of biological aging in mouse bone marrow leukocytes.
- DOI:10.1016/j.bbih.2022.100461
- 发表时间:2022-07
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Stress-induced biological aging: A review and guide for research priorities.
- DOI:10.1016/j.bbi.2022.05.016
- 发表时间:2022-08
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sleep Disruption, Fatigue, and Depression as Predictors of 6-Year Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation.
睡眠中断、疲劳和抑郁是同种异体造血细胞移植后 6 年临床结果的预测因子。
- DOI:10.1093/jnci/djab032
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Rentscher,KellyE;Carroll,JudithE;Juckett,MarkB;Coe,ChristopherL;Broman,AimeeT;Rathouz,PaulJ;Hematti,Peiman;Costanzo,ErinS
- 通讯作者:Costanzo,ErinS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kelly E Rentscher其他文献
Kelly E Rentscher的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kelly E Rentscher', 18)}}的其他基金
Accelerated biological and phenotypic aging in hematopoietic cell transplant survivors: Social support as a protective factor
造血细胞移植幸存者的生物和表型衰老加速:社会支持作为保护因素
- 批准号:
10055738 - 财政年份:2020
- 资助金额:
$ 11.43万 - 项目类别:
Accelerated biological and phenotypic aging in hematopoietic cell transplant survivors: Social support as a protective factor
造血细胞移植幸存者的生物和表型衰老加速:社会支持作为保护因素
- 批准号:
10242198 - 财政年份:2020
- 资助金额:
$ 11.43万 - 项目类别:
Accelerated biological and phenotypic aging in hematopoietic cell transplant survivors: Social support as a protective factor
造血细胞移植幸存者的生物和表型衰老加速:社会支持作为保护因素
- 批准号:
10543003 - 财政年份:2020
- 资助金额:
$ 11.43万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 11.43万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 11.43万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 11.43万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 11.43万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 11.43万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 11.43万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 11.43万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 11.43万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 11.43万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 11.43万 - 项目类别:
Research Grant